Expect the talk in Washington about the federal health care law to intensify as we approach the one-year anniversary of the passage of the Patient Protection and Affordable Care Act next week.

Congress is holding several hearings, including the Senate Finance Committee meeting on Wednesday morning to discuss “Health Reform: Lessons Learned During the First Year.”

On Thursday, the Senate health committee will take a look at the exchanges being developed to offer heath insurance and what the states need to do to implement the new law.

Meanwhile, in the House, the oversight committee’s health care subcommittee is holding a hearing on Tuesday about all the waivers federal regulators are granting under the new law.

On Thursday, the House Energy and Commerce Committee will take a look at the so-called Class program, a new national insurance plan for long-term care.

For those interested in following how this all plays out, Maine, which is the first state to receive a pass under the new health care, is holding some interesting public discussions this week. Anthem Blue Cross Blue Shield, which is part of for-profit insurer WellPoint, is asking for an increase in rates of nearly 10 percent for people who buy health insurance on their own. Regulators and the insurer have a long history in the state, so be prepared for a lot of back and forth.

You can find more of the details about the proposed public session in an Associated Press story that ran on Sunday.

The Food and Drug Administration will be talking innovation this week. On Tuesday, the agency will be holding a public day-long meeting about innovation in medical devices. The session will feature panel discussions with a range of participants from industry and academia.

The meeting is one of the outgrowths of a white paper the agency put out about the topic in February.

The F.D.A. will also try to make progress this week on a couple of controversial issues. On Thursday and Friday, in two half-day meetings, the Tobacco Products Scientific Advisory Committee will hear updates from the Menthol Report Subcommittee and discuss finishing a report regarding how menthol-flavored cigarettes impact public health.

Also on Thursday and Friday, the neurological devices panel of the Medical Devices Advisory Committee will meet to discuss some pending applications.

Let us know if we missed anything.